Jonathan Davies & Co., Law Firm

Medical law, Personal Injuries and Medical Malpractice

Jonathan Davies & Co., Law Firm
Profile Icon

Company's Profile

Established: 1988
Line of Business: Medical law, Personal Injuries and Medical Malpractice
Address: Shenhav House, 12 Beit Hadfus St., Jerusalem
Tel: 972-2-6529990 Fax: 972-2-6529995
Ha’arbaa Towers (South Building, 9th floor) 30 Ha’arba’a St., Tel Aviv
Phone: 972-3-7419190
Fax: 972-3-5610406
Email: [email protected]
Management Icon

Company Executives

  • Jonathan Davies, Jonathan Davies & Co., Law Firm

    Adv. Jonathan Davies

    Firm Owner. The firm has branches in Tel-Aviv and in Jerusalem.

    Jonathan Davies & Co., Law Firm

    View Profile

    Jonathan Davies
  • Ronit Lenman, Jonathan Davies & Co., Law Firm

    Adv. Ronit Lenman

    Senior Partner

    Jonathan Davies & Co., Law Firm

Icon About

About Jonathan Davies & Co., Law Firm

Jonathan Davies & Co. is one of Israel’s leading medical malpractice, torts and insurance law firms, with over 38 years of experience representing victims in various personal injury claims. Jonathan Davies is the President of the Society of Medicine and Law in Israel. The firm’s knowledge in Israeli and international medical law and its experience in complex medical law claims are expressed in each and every case, with the personal involvement of Adv. Jonathan Davies throughout the process. The firm, which was founded by Adv. Jonathan Davies in 1988, represents victims vs. state authorities (IDF, National Insurance), medical institutions (HMOs and government hospitals) and private entities (institutions, physicians, clinics, insurers) in liability, torts, insurance, medical law, medical malpractice claims, and general civil law litigations and representation. In addition, the firm provides legal consulting on Bio-Ethics, Biotechnology and medical ethics and was involved in precedential rulings. The firm also provides consulting services to other law firms, and represents the National Insurance Institution in subrogation claims against insurance companies. The firm, which handles the most complex medical malpractice claims, uses the services of Israel’s best medical experts. It aspires for optimal legal results with attention to all of the social rights for which the victims are entitled. Since 2020 at the heat of the Covid-19 pandemic the firm filed 70 different medical malpractice claims many of them on behalf of parents who adopted children that were adopted from foster homes in East European countries. The children suffer from Fetal Alcohol Syndrome Disorder (FASD). This are unprecedented claims arguing for ‘wrongful adoption’ and going to set a legal, medical and social precedent. The individual tort claims have an international impact on adoption.
In the past year, the Firm filed a petition for a class action against Pharmaceutical companies who sold a drug that supposed to avoid her lose (Finasteride) that caused them anxiety and depression following a personal injury case that the firm filed on behalf of an estate of a person who committed suicide after using the drug for 7 days.

Legal Precedents

In its three decades of operations, the firm set numerous precedents in the Supreme Court and the National Labor Court, and led to numerous binding precedents that serve as pillars of Israeli medical law, including a ruling of the Supreme Court President Shamgar that regulates disclosure obligations of insurers to the insured, a patient rights’ ruling which determines that a lack of sufficient experience of an Israeli doctor justifies funding surgery abroad, a ruling concerning the relative deduction of benefits from tort compensations, and a ruling concerning wrongful birth, that served as a basis for a binding precedent of the Supreme Court, determining that an Ultra-Orthodox woman can decide to abort, regardless of her religious beliefs. In addition, a ruling concerning the Spoliation of medical records by a senior physician, and an important recent ruling concerning the required follow-up after a Sleeve Gastrectomy procedure. The firm aims to reformulate the patient-medical-staff relationship through a precedential lawsuit concerning a physician who died following “Sham Peer Review” from his colleagues. Thus, the firm exposes the behind-the-scene dynamics of hospitals and fights for the right of patients to know of such dynamics. Additional precedents include rulings concerning patients’ rights under the National Health Insurance Law, medical malpractice in various medical fields, obstetrics complications, surgery complications, misdiagnosis, medication and prescription errors, insurance and tort claims, chemicals/radiation exposure torts, accidents and medical experts.

Innovative Projects in the Practice Area

The firm’s commitment to defend medical malpractice victims leads to an implementation of its accumulated knowledge in two innovative projects, aimed at implementing their rights, and supporting them through the obstacles of the legal procedures, and at reducing the high costs that are involved in legal and expert opinions and representation in this area. For that purpose, the firm is involved in the creation of innovative tools that help victims fund medical opinions. The firm is handling a magnitude claim on behalf of 45 parents and children that were adopted from East European countries that suffer from Fetal Alcohol Syndrome. The claims are against the Doctors and adoption agencies that did not diagnose the syndrome and the state of Israel that allowed the interstate adoption without reasonable care.
Justice Investments – This Enterprise concerns legal investments and helps finance medical opinions and legal expenses for the victims on a Win Win basis. Jonathan Davies is the chair of the investment committee.

Adv. Jonathan Davies

Adv. Davies has an LL.B., Tel Aviv University (1993) and an LL.M. (Commercial Law, magna sum laude), Tel Aviv University with UC Berkeley (2012). He has 34 years of experience in medical malpractice, torts, insurance, liability, litigation, medicine and law, occupational illnesses, bodily harm, OSH, receiving medical rights, bio-tech and class actions. He was the chief editor of the “Medicine and Law” journal of the Israeli Law and Medicine Association for 15 years. Jonathan Davies is the new President of the Society of Medicine and Law in Israel. In addition, he was Chairman of the Council of Presidents of the WAML. Member in the Board of Governors of WAML and member of the educational committee. Executive and presidential board member of the Medicine and Law Association, Member of the management board of the Health, Law and Ethics center next to Haifa University and Member of the British Royal Society of Medicine. He is also a Member of the US ACLM), a Member of the Helsinki Committee which approves/rejects human experiments for the Meuhedet HMO and a Bar-certified mediator. Since June 2022 He is the President of the Society of Medicine and Law in Israel. He is renowned as an authority in his field and published numerous books and articles in Hebrew and in English.
Some of his books:
• Laws and Rulings in Medical Law (1999)
• The Right to a Life with no Malformation, a collection of science, ethics and law articles (2007)
• “Legal Aspects of Alternative Medicine “Chapter in J. Shoval and E. Averbuch’s book - Alternative and Complementary Medicine (2014)
• “Legal and Forensic Medicine in Israel” Chapter in the International Medicine and Law Encyclopedia, Springer, Germany (2013).
• In 2022 the Encyclopedia was updated with a new chapter under the title “Public Health Care Law and Ethics in Israel”
He is also academically active as a lecturer in courses for medical expert’s opinions by the Medical Professions Union and the Attorneys Training Institute. Guest Editor of WAML’s Newsletter March 2020.

Ratings Icon

Company Rankings

Icon Publications


Articles Icon

Articles about Jonathan Davies & Co., Law Firm

You may also like

  • The 2022 Leaders in Law Forum

    On February 23, 2002, we held the Duns 100 Forum for Senior Legal Professionals.

    The 2022 Leaders in Law Forum

  • High–tech legal forum 2022

    On Wednesday, March 9, 2002, the Royal Beach Hotel Tel Aviv hosted the annual Duns 100 forum of senior Israeli legal professionals in the high-tech field with the participation of senior Dun & Bradstreet executives in Israel, Ami Applebaum, Chairman of the Innovation Authority and Chief Scientist at the Ministry of Economy.

    High–tech legal forum 2022

  • Patenting Antibodies in the US and the EU

    Antibody-based therapeutics play a central role in medicine and patent protection is critical to reaping the financial benefits from such successful therapeutic agents. Recent occurrences suggest that the barriers to securing broad patent protection in the US have increased. Innovative companies should develop and practice proper patent strategies ensuring that they receive the proper exclusionary patent protection that antibody-related innovations deserve.

    Patenting Antibodies in the US and the EU

  • Y.Ben–Dror's International Practice

    Y.Ben–Dror's International Practice